Skip to content
Molecules
SEKISUI XenoTech DD Blog Logo

Hepatosure Hepatocytes: The Largest Donor Pool For Your DMPK Applications

Pooled human hepatocytes can complement a selection of hepatocytes from various species for metabolite profiling, species comparison and evaluation of potential human-specific metabolites. HepatoSure® is the largest pool of human hepatocytes available without the expense of custom pooling, and is designed to facilitate your DMPK applications. HepatoSure® is best suited for both discovery and development of ADME-Tox study assays where generation and comparison of data is required. Let’s take a closer look…

Including 100 individual donors (from mixed gender) with little variation from lot-to-lot and large lot sizes, HepatoSure®enables you to minimize assay setup and validation repeats associated with changing donors and lots. The utility of HepatoSure® has been demonstrated with drugs whose hepatic clearance is mediated by various combinations of CYP, UGT and AO activities. Applications recommended for HepatoSure®  include evaluation of hepatic metabolism (both CYP and non-CYP enzymes), transporter-mediated uptake, enzyme or transporter inhibition and metabolite profiling and identification.

What are the main benefits of HepatoSure®?

  • 100 donors (reduced inter-individual variability)
  • High viability and enzyme activity levels
  • Extensively characterized using LC-MS/MS methods
  • High quality, reproducible hepatocytes

HepatoSure® – highly characterised

Each lot of HepatoSure® is characterized for activity of several CYPs and other DME enzymes, including multiple cytochrome P450s, UDP-Glucuronosyltransferases (UGT), Sulfotransferases (SULT) and aldehyde oxidase (AO). Several additional drug metabolizing enzyme activities can be characterized upon request as a custom service. The complement of these hepatic enzymes enables the evaluation of several types of metabolism endpoints. HepatoSure® can be used for short- and long-term metabolic clearance studies in suspension and enzyme phenotyping in the presence or absence of specific chemical inhibitors of CYP and/or non-CYP enzymes.

HepatoSure pool of hepatocytes – characterisation information (SEKISUI Xenotech at tebu-bio)

Transporters: Each lot of HepatoSure® is characterized for several hepatic uptake transporters, including OATP1B1 (estrone-3-sulfate), OATP1B3 (CCK-8), OCT1 (MPP+) and NTCP (taurocholate). HepatoSure® serves as an excellent tool to evaluate whether a drug candidate is a substrate for active hepatic uptake with the oil-spin or medium loss methods and, furthermore, to determine active and passive uptake clearances with the aforementioned experimental approaches. Lysosomal trapping or sequestration can also be evaluated with HepatoSure®. Additionally, Transporter phenotyping can be conducted with methods that employ chemical inhibitors (transporter specific).

Transporter or Enzyme Inhibition: With a full complement of drug metabolizing enzymes and transporters, HepatoSure® is an excellent tool for evaluation of enzyme or transporter inhibition. The large number of donors and large lot sizes minimizes the contribution of a single individual or sub-population (e.g. CYP2D6 PM’s) and enables rapid assay development and validation when new lots are needed.

HepatoSure pool of hepatocytes – minimum lot-to-lot variability

HepatoSure® OptiThaw Kit – guaranteed post-thaw viability

SEKISUI XenoTech’s HepatoSure® pooled human cryopreserved hepatocytes are shipped with a HepatoSure® OptiThaw Kit. This kit contains optimized, proprietary media to ensure consistent yield and high viability post-thaw. Each kit is sufficient to thaw and isolate up to three 1.5mL vials of HepatoSure®. When using the OptiThaw kit per SEKISUI XenoTech’s optimized protocols, HepatoSure® pooled cryopreserved human hepatocyte products are guaranteed to yield a post-thaw viability of 70% or higher.

HepatoSure® – optimal performance, lower cost

HepatoSure® was tested against a comparable product currently on the market and demonstrated similar viability, enzymatic activity and overall performance. Costing less than the competition, HepatoSure® includes 100 donors, provides the necessary media for thawing and isolation (HepatoSure® OptiThaw Kit) and delivers high quality, consistent hepatocytes. HepatoSure® is a pooled human hepatocyte product designed to facilitate DMPK applications with a more consistent hepatocyte product year after year.

HepatoSure® – what you’ll receive

  • 1.5 mL (item ref. HCP100.H15)
  • 5 million cells AMY (Assured Minimum Yield)
  • HepatoSure™ OptiThaw Kit included

Contact us if you wish to receive any additional information on Hepatosure or the other products we can provide for your ADME-Tox studies (single-freeze smaller pools or individual donor hepatocytessubcellular fractions with high custom possibilities and much more.

Originally published in tebu-bio’s Being Bioreactive. To purchase SEKISUI XenoTech’s products in the EU, please visit tebu-bio’s website.

Learn more about:

About the Authors

Subscribe to our Newsletter

Stay up to date with our news, events and research

In vitro pipette test article treatment
005 International Messaging Created with Sketch.

Do you have a question or a request for upcoming blog content?

We love to get your feedback

A scientist utlilizing a microplate